Identification of triptonide as a therapeutic agent for triple negative breast cancer treatment

MLA

Xiaojiang Cui, et al. “Identification of Triptonide as a Therapeutic Agent for Triple Negative Breast Cancer Treatment.” Scientific Reports, vol. 11, no. 1, Jan. 2021, pp. 1–10. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....d5cd1e822e88ffdc981cc5e916fdfa3f&authtype=sso&custid=ns315887.

APA

Xiaojiang Cui, Bowen Gao, Yukun Cui, Xinfeng Zhang, Jiongyu Chen, Jijun Hao, Armando E. Giuliano, & Bingchen Han. (2021). Identification of triptonide as a therapeutic agent for triple negative breast cancer treatment. Scientific Reports, 11(1), 1–10.

Chicago

Xiaojiang Cui, Bowen Gao, Yukun Cui, Xinfeng Zhang, Jiongyu Chen, Jijun Hao, Armando E. Giuliano, and Bingchen Han. 2021. “Identification of Triptonide as a Therapeutic Agent for Triple Negative Breast Cancer Treatment.” Scientific Reports 11 (1): 1–10. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....d5cd1e822e88ffdc981cc5e916fdfa3f&authtype=sso&custid=ns315887.